PL
PL · PL · PL-100512559
Lazcluze
ATC L01EB09
Last synced from URPL (Poland) on
Identification
ManufacturerJanssen-Cilag International N.V.
CountryPL (PL)
ATC codeL01EB09
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05413868125788
- gtin04150192109350
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "240 mg",
"packaging": "Rpz ¦ EU/1/24/1886/004 ¦ 160270\n14 tabl.\n05413868125788 ¦ Rpz ¦ EU/1/24/1886/005 ¦ 160271\n28 tabl.\n¦ UR/Z/4c/016/25 - 04150192109350\nRpz ¦ EU/1/24/1886/006 ¦ 160272\n30 tabl.",
"substance": "Lazertinib 240 mg",
"common_name": "Lazertinib",
"pl_product_id": "100512559",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L01EB09.
Access this data programmatically
Query Lazcluze and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.